Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Overview of This Study:

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global in situ hybridization market.

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the ISH market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Major Growth Boosting Factors:

The increasing incidence and prevalence of cancer and genetic disorders and awareness about companion diagnostics tests in ISH are the major factors driving the growth of this market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=212028829

Revenue Growth Projections During Forecast Period:

The global in situ hybridization market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.

COVID-19 Impact on the Global In Situ Hybridization Market:

The COVID-19 outbreak is an unprecedented global public health challenge and is expected to have a significant impact on the ISH market for diagnostics and research applications.

Although RT-PCR is widely used to detect and diagnose coronavirus in human samples, researchers and diagnostics companies across the globe are finding cost-effective and sensitive assay kits to deal with the pandemic. Molecular cytogenetics tests such as ISH play a role in identifying infected cells or tissue. As a result, in 2020, some companies in this market have focused on launching COVID-19 specific probes.

A US-based firm, Creative Bioarray (US), launched a 2019 Novel Coronavirus Detection FISH Probe for the detection of viral particles in cells.

Bio-Techne (US), is helping researchers with its RNAscope technology that allows the visualization of viral loads in cell and tissues using its V-nCoV2019-S probe.

With its applications in infectious disease diagnostics, the impact of COVID will have a short-term positive effect on the ISH market.

Opportunity: Untapped markets in developing countries

In developed countries, high-quality molecular diagnostic tests are readily available. However, in developing countries, the cost of these diagnostic technologies is very high, which often makes them unaffordable for a large part of the population. Moreover, the lack of a commercial market for diagnostic procedures has resulted in the availability of a small number of diagnostic tests in developing countries.

As a result, emerging markets such as India, China, Brazil, offer significant growth opportunities for MDx-based technology (including ISH) owing to the rising geriatric population, the growing prevalence of infectious diseases and various types of cancers, improving healthcare infrastructure, and increasing investments by respective government bodies and leading players in these countries.

Geographical Growth Scenario:

North America accounted for the largest share of the global In Situ Hybridization Market in 2019.

In 2019, North America accounted for the largest share of the In Situ Hybridization Market. The increasing incidence of cancer and infectious diseases in the region is driving the focus on the development of personalized medicine and diagnostics tests. As a result, due to the strong demand for early cancer detection capabilities, the market for ISH-based diagnostic tests is expected to see steady growth. In addition, the region is home to a large base of clinical research laboratories and academic institutes.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=212028829

Key Players:

The prominent players operating in the In Situ Hybridization Market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), and Danaher Corporation (US).

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe